Loading
Latest filing published 23 Nov 2021 for Utah Medical Products INC, €221k.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin L. Cornwell is a declared insider of Utah Medical Products Inc (chief executive), with filings sourced from SEC (Form 4). We count 88 filings; the first trade dates from 3 January 2006 and the latest from 22 November 2021.
The open-market side counts 3 purchases for €77k alongside 71 sales for €7.0M. The net balance comes to €6.9M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants and 8 option exercises.
In size, the median ticket on the buying side is €36k. After 3 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +5.1%. These figures describe past trades and do not predict future prices.
The record was last updated on 23 November 2021 with a transaction (€221k) in Utah Medical Products Inc. The most recent open-market purchase was published on 15 August 2011, 5,549 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 88 declarations